Department of Medicine

Welcome to the Division of Endocrinology, Diabetes and Metabolism

Mission

The Division of Endocrinology, Diabetes and Metabolism functions administratively within the Department of Medicine.  The Division consists of several faculty members, clinicians and investigators, each with unique multidisciplinary backgrounds who strive to maintain the excellence of service and education provided by the University of Toledo College of Medicine and Life Sciences (formerly the Medical College of Ohio), and also further the proliferation of important research in the field of Endocrinology, Diabetes and Metabolism. 

The Division of Endocrinology, Diabetes and Metabolism at the University of Toledo focuses on education and cutting edge research in the field of medicine that pertains to the endocrine system, its diseases, and the events which arise from the secretion and metabolism of hormones.  Students, Residents, Fellows and other trainees gain academic and hands-on experience in laboratory and clinical environments provided by the University of Toledo Medical Center, CeDER (Center for Diabetes and Endocrine Research) and now the academic affiliate ProMedica Health System of northwest Ohio and southeast Michigan. View Academic Affiliation video


CONTACT US

Julie LaPlante
Division Coordinator
3000 Arlington Ave. 
Mail Stop 1186 
Toledo, OH 43614 
Phone: (419) 383-3720
Fax: (419) 383-6285 
julie.laplante2@utoledo.edu

Clinic headquarters:
Falzone Diabetes Center
UT-ProMedica Academic Endocrinology
2100 W. Central Ave.  Toledo, OH 43606.   Phone: (567) 420-1600
Jennifer Spencer, MA

Support Our Mission

Give Now

Give to the Division of Endocrinology, Diabetes and Metabolism Research Fund.

Type fund # 2402325 as your gift designation to support our patient care mission, research program and educational activities.

 

President highlights our work!  



Division News

Image result for nature group publishing
TWO (2) NATURE GROUP PAPERS PUBLISHED BACK-TO-BACK in 2019!

 

1-Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer.

2-eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes.


Dr. Jaume meets Congresswoman Marcy Kaptur to celebrate Congress passage of Special Diabetes Program (SDP)

c


The UToledo Division of Endocrinology, Diabetes and Metabolism and the ProMedica Endocrine Section have now teamed up!

Academic Affiliation Logo


Division makes big splash at The Endocrine Society 2017 Annual Meeting, Orlando, FL (7 abstracts!!!)

 ENDO 2017 ABSTRACTS


 Dr. Jaume's interview with Healthy Living News November 2016

http://www.hjntoledo.com/health-and-beauty-f/317-2016/novenber/1532-new-diabetes-management-methods-help-take-stress-out-of-holiday-eating


 Dr. Jaume receives the 2016 "H. Donabedian Faculty Teaching Award"

Plaque 


 The Endocrine Society Annual Meeting, Boston MA 2016:

Abstract received the prestigious "Helmsley Charitable Trust Award in Type 1 Diabetes"

ENDO 2016

From left to right, authors of the work, Drs. Sirinvaravong, Jaume and Hao.


 Dr. Ergun-Longmire discusses prevention of pediatric Type 2 Diabetes for The Blade

The Balde article

http://www.toledoblade.com/Medical/2016/03/21/Family-lifestyle-change-can-ward-off-Type-2-Diabetes.html


Dr. Jaume discusses increased prevalence of thyroid diseases for NBC channel 24

 Jaume CeDER

http://nbc24.com/features/24-better-living/better-living-utmc-dr-juan-jaume


 

Last Updated: 2/12/20